128 related articles for article (PubMed ID: 38365562)
1. Deciphering Fc-effector functions against SARS-CoV-2.
Beaudoin-Bussières G; Finzi A
Trends Microbiol; 2024 Feb; ():. PubMed ID: 38365562
[TBL] [Abstract][Full Text] [Related]
2. Cell-based reporter assays for measurements of antibody-mediated cellular cytotoxicity and phagocytosis against SARS-CoV-2 spike protein.
Hong Y; Guo H; Wei M; Zhang Y; Fang M; Cheng T; Li Z; Ge S; Yao X; Yuan Q; Xia N
J Virol Methods; 2022 Sep; 307():114564. PubMed ID: 35671888
[TBL] [Abstract][Full Text] [Related]
3. Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination.
Motsoeneng BM; Manamela NP; Kaldine H; Kgagudi P; Hermanus T; Ayres F; Makhado Z; Moyo-Gwete T; van der Mescht MA; Abdullah F; Boswell MT; Ueckermann V; Rossouw TM; Madhi SA; Moore PL; Richardson SI
Front Immunol; 2023; 14():1231276. PubMed ID: 37600825
[TBL] [Abstract][Full Text] [Related]
4. Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease.
van Erp EA; Luytjes W; Ferwerda G; van Kasteren PB
Front Immunol; 2019; 10():548. PubMed ID: 30967872
[TBL] [Abstract][Full Text] [Related]
5. Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection.
Zhang A; Stacey HD; D'Agostino MR; Tugg Y; Marzok A; Miller MS
Nat Rev Immunol; 2023 Jun; 23(6):381-396. PubMed ID: 36536068
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions.
Adeniji OS; Giron LB; Purwar M; Zilberstein NF; Kulkarni AJ; Shaikh MW; Balk RA; Moy JN; Forsyth CB; Liu Q; Dweep H; Kossenkov A; Weiner DB; Keshavarzian A; Landay A; Abdel-Mohsen M
mBio; 2021 Apr; 12(2):. PubMed ID: 33879594
[TBL] [Abstract][Full Text] [Related]
7. Coronavac inactivated vaccine triggers durable, cross-reactive Fc-mediated phagocytosis activities.
Wang L; Li C; Li W; Zhao L; Zhao T; Chen L; Li M; Fan J; Li J; Wu C; Chen Y
Emerg Microbes Infect; 2023 Dec; 12(2):2225640. PubMed ID: 37309826
[TBL] [Abstract][Full Text] [Related]
8. Decay of Fc-dependent antibody functions after mild to moderate COVID-19.
Lee WS; Selva KJ; Davis SK; Wines BD; Reynaldi A; Esterbauer R; Kelly HG; Haycroft ER; Tan HX; Juno JA; Wheatley AK; Hogarth PM; Cromer D; Davenport MP; Chung AW; Kent SJ
Cell Rep Med; 2021 Jun; 2(6):100296. PubMed ID: 33997824
[TBL] [Abstract][Full Text] [Related]
9. Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Immunoglobulin Demonstrates Potent Neutralization and Antibody-Dependent Cellular Cytotoxicity and Phagocytosis Through N and S Proteins.
Díez JM; Romero C; Cruz M; Vandeberg P; Merritt WK; Pradenas E; Trinité B; Blanco J; Clotet B; Willis T; Gajardo R
J Infect Dis; 2022 Mar; 225(6):938-946. PubMed ID: 34693968
[TBL] [Abstract][Full Text] [Related]
10. Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma.
Natarajan H; Crowley AR; Butler SE; Xu S; Weiner JA; Bloch EM; Littlefield K; Wieland-Alter W; Connor RI; Wright PF; Benner SE; Bonny TS; Laeyendecker O; Sullivan D; Shoham S; Quinn TC; Larman HB; Casadevall A; Pekosz A; Redd AD; Tobian AAR; Ackerman ME
mBio; 2021 Apr; 12(2):. PubMed ID: 33879585
[TBL] [Abstract][Full Text] [Related]
11. Reduced neutralization and Fc effector function to Omicron subvariants in sera from SARS-CoV-1 survivors after two doses of CoronaVac plus one dose subunit vaccine.
Chen D; Li X; Hao X; Qiu Y; Song Y; Sun H; Liu Y; Du J; Zhang Y; Xiao F; Song C; Yan Y; Song R; Wang X; Zhao X; Jin R
J Med Virol; 2023 Oct; 95(10):e29136. PubMed ID: 37804496
[TBL] [Abstract][Full Text] [Related]
12. A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection.
Beaudoin-Bussières G; Chen Y; Ullah I; Prévost J; Tolbert WD; Symmes K; Ding S; Benlarbi M; Gong SY; Tauzin A; Gasser R; Chatterjee D; Vézina D; Goyette G; Richard J; Zhou F; Stamatatos L; McGuire AT; Charest H; Roger M; Pozharski E; Kumar P; Mothes W; Uchil PD; Pazgier M; Finzi A
Cell Rep; 2022 Feb; 38(7):110368. PubMed ID: 35123652
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals.
Richardson SI; Madzorera VS; Spencer H; Manamela NP; van der Mescht MA; Lambson BE; Oosthuysen B; Ayres F; Makhado Z; Moyo-Gwete T; Mzindle N; Motlou T; Strydom A; Mendes A; Tegally H; de Beer Z; Roma de Villiers T; Bodenstein A; van den Berg G; Venter M; de Oliviera T; Ueckermann V; Rossouw TM; Boswell MT; Moore PL
Cell Host Microbe; 2022 Jun; 30(6):880-886.e4. PubMed ID: 35436444
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of Antibody-Dependent Cellular Cytotoxicity and Phagocytosis in Anti-HIV-1 Human-Bovine Chimeric Broadly Neutralizing Antibodies.
Edwards JM; Heydarchi B; Khoury G; Salazar-Quiroz NA; Gonelli CA; Wines B; Hogarth PM; Kristensen AB; Parsons MS; Purcell DFJ
J Virol; 2021 Jun; 95(13):e0021921. PubMed ID: 33853957
[TBL] [Abstract][Full Text] [Related]
15. Coordinated Fc-effector and neutralization functions in HIV-infected children define a window of opportunity for HIV vaccination.
Nduati EW; Gorman MJ; Sein Y; Hermanus T; Yuan D; Oyaro I; Muema DM; Ndung'u T; Alter G; Moore PL
AIDS; 2021 Oct; 35(12):1895-1905. PubMed ID: 34115644
[TBL] [Abstract][Full Text] [Related]
16. Fc-mediated functions of nirsevimab complement direct respiratory syncytial virus neutralization but are not required for optimal prophylactic protection.
Brady T; Cayatte C; Roe TL; Speer SD; Ji H; Machiesky L; Zhang T; Wilkins D; Tuffy KM; Kelly EJ
Front Immunol; 2023; 14():1283120. PubMed ID: 37901217
[TBL] [Abstract][Full Text] [Related]
17. A Recent SARS-CoV-2 Infection Enhances Antibody-Dependent Cellular Cytotoxicity against Several Omicron Subvariants following a Fourth mRNA Vaccine Dose.
Beaudoin-Bussières G; Tauzin A; Dionne K; Gendron-Lepage G; Medjahed H; Perreault J; Levade I; Alfadhli L; Bo Y; Bazin R; Côté M; Finzi A
Viruses; 2023 May; 15(6):. PubMed ID: 37376574
[TBL] [Abstract][Full Text] [Related]
18. Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2.
Wines BD; Kurtovic L; Trist HM; Esparon S; Lopez E; Chappin K; Chan LJ; Mordant FL; Lee WS; Gherardin NA; Patel SK; Hartley GE; Pymm P; Cooney JP; Beeson JG; Godfrey DI; Burrell LM; van Zelm MC; Wheatley AK; Chung AW; Tham WH; Subbarao K; Kent SJ; Hogarth PM
Front Immunol; 2022; 13():889372. PubMed ID: 35967361
[TBL] [Abstract][Full Text] [Related]
19. Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses.
Tay MZ; Wiehe K; Pollara J
Front Immunol; 2019; 10():332. PubMed ID: 30873178
[TBL] [Abstract][Full Text] [Related]
20. mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern.
Kaplonek P; Fischinger S; Cizmeci D; Bartsch YC; Kang J; Burke JS; Shin SA; Dayal D; Martin P; Mann C; Amanat F; Julg B; Nilles EJ; Musk ER; Menon AS; Krammer F; Saphire EO; Andrea Carfi ; Alter G
Immunity; 2022 Feb; 55(2):355-365.e4. PubMed ID: 35090580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
